On ECHEMI
Home > Drugs > Osteodystrophy in children
Osteodystrophy in children
Fibrous osteodystrophy syndrome is McCune-Albright syndrome, also known as multiple osteofibrosis (osteitis fibrosa disseminate), osteodystrophy (osteodystrophia fibrosa), multiple fibrous osteodysplasia, multiple fibrous dysplasia, multiple fibrous dysplasia, Albright syndrome, Albright-McCune-Stenberg syndrome, brown spot syndrome, fibrous dysplasia-pigmentation syndrome. Its main clinical features are: ① multiple fibrous dysplasia, fibrous osteitis, pathological fractures, etc.; ② skin pigmentation, yellow-brown or dark-brown pigmented spots with irregular edges, and the pigmentation is often distributed in the corresponding skin area of the diseased bone or at the level of the nerve segment; ③ various endocrine abnormalities, often precocious puberty, hyperthyroidism, gigantism or acromegaly, hyperparathyroidism, Cushing's syndrome, vitamin D-resistant rickets, etc.
  • Site of disease:

    Upper limb bones Lower limb bones
  • Infectious :

    Not contagious
  • Frequent population:

    child
  • Related symptoms:

    Increased alkaline phosphatase Multiple nodules Goiter Urine phosphorus Hypophosphatemia
  • Concurrent disease:

Related Drugs
Children's Changweikang Granule
Manufacturer:

Jiangxi Pinxin Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.